Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · 147-155
DOI: 10.1016/j.ijrobp.2026.03.002 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Shijiang Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences,…. Hauptthemen laut MEDLINE: Thrombocytopenia, Thrombopoietin, Chemoradiotherapy, Small Cell Lung Carcinoma. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
- Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
- Department of Medical Oncology, Henan Provincial People's Hospital, Zhengzhou, China.
- Department of Medical Oncology, Anshan Cancer Hospital, Anshan, China.
- Department of Medical Oncology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
Zitieren
APA
Wang, S., Zhao, F., Wang, J., Hua, Y., Ji, Y., Wang, C., Man, L., Zhang, Z., Chen, J., Chen, J., Li, H., Ma, X., Liang, Z., Meng, X., Wang, J., Zhang, X., Yu, J., & Wang, L. (2026). Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), 147-155. https://doi.org/10.1016/j.ijrobp.2026.03.002
Vancouver
Wang S, Zhao F, Wang J, Hua Y, Ji Y, Wang C, et al. Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):147-155. doi:10.1016/j.ijrobp.2026.03.002
BibTeX
@article{Wang2026,
author = {Wang, Shijiang and Zhao, Fen and Wang, Jin and Hua, Ying and Ji, Yongling and Wang, Chaojie and Man, Li and Zhang, Zhiye and Chen, Jun and Chen, Jianbing and Li, Hongmei and Ma, Xuezhen and Liang, Zhaohui and Meng, Xianyu and Wang, Jun and Zhang, Xiaozhi and Yu, Jinming and Wang, Linlin},
title = {Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {147--155},
doi = {10.1016/j.ijrobp.2026.03.002}
}
EUVIMED